Tag: Pennington
Pennington Biomedical Researchers Participated in Eight-Year Long GRADE Study on Commonly Used Type 2 Diabetes Medications
Diabetes affects more than 1 in 10 — or more than 38 million — Americans. People with diabetes who keep their blood sugar levels in the near-normal range generally have a much lower risk of developing diabetes complications such as heart, kidney, and eye diseases. The challenge is that most people with diabetes require more than one medication to control blood sugar levels over time. The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness, or GRADE, Study was designed to compare four major medications approved by the FDA to treat diabetes in combination with metformin, the usual first-line drug. Major ... Read more